158 related articles for article (PubMed ID: 19387655)
1. Survival following treatment for intracranial ependymoma: a review.
Tamburrini G; D'Ercole M; Pettorini BL; Caldarelli M; Massimi L; Di Rocco C
Childs Nerv Syst; 2009 Oct; 25(10):1303-12. PubMed ID: 19387655
[TBL] [Abstract][Full Text] [Related]
2. Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.
Andreiuolo F; Le Teuff G; Bayar MA; Kilday JP; Pietsch T; von Bueren AO; Witt H; Korshunov A; Modena P; Pfister SM; Pagès M; Castel D; Giangaspero F; Chimelli L; Varlet P; Rutkowski S; Frappaz D; Massimino M; Grundy R; Grill J;
PLoS One; 2017; 12(6):e0178351. PubMed ID: 28617804
[TBL] [Abstract][Full Text] [Related]
3. Ependymomas: development of immunotherapeutic strategies.
Pollack IF; Jakacki RI; Butterfield LH; Okada H
Expert Rev Neurother; 2013 Oct; 13(10):1089-98. PubMed ID: 24117271
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
[TBL] [Abstract][Full Text] [Related]
5. Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis.
Zacharoulis S; Ashley S; Moreno L; Gentet JC; Massimino M; Frappaz D
Childs Nerv Syst; 2010 Jul; 26(7):905-11. PubMed ID: 20039045
[TBL] [Abstract][Full Text] [Related]
6. Outcomes following management of relapsed pediatric posterior fossa ependymoma in the molecular era.
Malhotra AK; Nobre LF; Ibrahim GM; Kulkarni AV; Drake JM; Rutka JT; Bouffet E; Taylor MD; Tsang D; Ramaswamy V; Dirks PB; Dewan MC
J Neurooncol; 2023 Feb; 161(3):573-582. PubMed ID: 36757527
[TBL] [Abstract][Full Text] [Related]
7. Ependymoma Pediatric Brain Tumor Protein Fingerprinting by Integrated Mass Spectrometry Platforms: A Pilot Investigation.
Rossetti DV; Massimi L; Martelli C; Vincenzoni F; Di Silvestre S; Scorpio G; Tamburrini G; Caldarelli M; Urbani A; Desiderio C
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183175
[TBL] [Abstract][Full Text] [Related]
8. Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.
Tsang DS; Murray L; Ramaswamy V; Zapotocky M; Tabori U; Bartels U; Huang A; Dirks PB; Taylor MD; Hawkins C; Bouffet E; Laperriere N
Neuro Oncol; 2019 Mar; 21(4):547-557. PubMed ID: 30452715
[TBL] [Abstract][Full Text] [Related]
9. Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas.
Liang ML; Hsieh TH; Liu YR; Chen YW; Lee YY; Chang FC; Lin SC; Huang MC; Donald Ming-Tak H; Wong TT; Yen Y; Yang MH
Oncotarget; 2018 Jan; 9(2):2527-2542. PubMed ID: 29416789
[TBL] [Abstract][Full Text] [Related]
10. Ependymomas: Prognostic Factors and Outcome Analysis in a Retrospective Series of 33 Patients.
Chai YH; Jung S; Lee JK; Kim IY; Jang WY; Moon KS; Kim JH; Lee KH; Kim SK; Jung TY
Brain Tumor Res Treat; 2017 Oct; 5(2):70-76. PubMed ID: 29188207
[TBL] [Abstract][Full Text] [Related]
11. Quantitative imaging analysis of posterior fossa ependymoma location in children.
Sabin ND; Merchant TE; Li X; Li Y; Klimo P; Boop FA; Ellison DW; Ogg RJ
Childs Nerv Syst; 2016 Aug; 32(8):1441-7. PubMed ID: 27117266
[TBL] [Abstract][Full Text] [Related]
12. Overcoming Chemoresistance of Pediatric Ependymoma by Inhibition of STAT3 Signaling.
Phi JH; Choi SA; Kim SK; Wang KC; Lee JY; Kim DG
Transl Oncol; 2015 Oct; 8(5):376-386. PubMed ID: 26500028
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation.
Kievit FM; Stephen ZR; Wang K; Dayringer CJ; Sham JG; Ellenbogen RG; Silber JR; Zhang M
Mol Oncol; 2015 Jun; 9(6):1071-80. PubMed ID: 25681012
[TBL] [Abstract][Full Text] [Related]
14. Cerebellopontine angle ependymoma in a 2-year- old child.
Salunke P; Sharma M; Gupta K; Kovai P; Aggarwal A
J Neurosci Rural Pract; 2012 May; 3(2):200-3. PubMed ID: 22865982
[TBL] [Abstract][Full Text] [Related]
15. Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007.
Amirian ES; Armstrong TS; Aldape KD; Gilbert MR; Scheurer ME
Neuroepidemiology; 2012; 39(2):116-24. PubMed ID: 22846789
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas.
Yang I; Nagasawa DT; Kim W; Spasic M; Trang A; Lu DC; Martin NA
J Clin Neurosci; 2012 Jun; 19(6):779-85. PubMed ID: 22516549
[TBL] [Abstract][Full Text] [Related]
17. Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology.
Phi JH; Wang KC; Park SH; Kim IH; Kim IO; Park KD; Ahn HS; Lee JY; Son YJ; Kim SK
J Neurooncol; 2012 Feb; 106(3):619-26. PubMed ID: 21863401
[TBL] [Abstract][Full Text] [Related]
18. Challenging issues in pediatric oncology.
Pui CH; Gajjar AJ; Kane JR; Qaddoumi IA; Pappo AS
Nat Rev Clin Oncol; 2011 Jun; 8(9):540-9. PubMed ID: 21709698
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations.
Stephen MD; Zage PE; Waguespack SG
Int J Pediatr Endocrinol; 2011; 2011(1):184502. PubMed ID: 21603196
[TBL] [Abstract][Full Text] [Related]
20. Apurinic/apyrimidinic endonuclease is inversely associated with response to radiotherapy in pediatric ependymoma.
Bobola MS; Jankowski PP; Gross ME; Schwartz J; Finn LS; Blank A; Ellenbogen RG; Silber JR
Int J Cancer; 2011 Nov; 129(10):2370-9. PubMed ID: 21207372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
